Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000346831

Medchemexpress LLC PA452 | 457657-34-0 | ≥99.0% | 439.59 | 1 MG
SDP

Supplier:  Medchemexpress LLC HY1085221MG

Encompass_Preferred

PA452 is a specific antagonist of the retinoic X receptor (RXR) that inhibits the effect of Retinoic acid (RA) on Th1/Th2 development. In vitro, PA452 inhibits Troglitazone (TZ)-induced CK13 expression and inhibits RXR in normal human urothelial (NHU) cells.

  • Specific antagonist of the retinoic X receptor (RXR)
  • Inhibits the effect of retinoic acid (RA) on Th1/Th2 development
  • Inhibits Troglitazone (TZ)-induced CK13 expression
  • Inhibits RXR in normal human urothelial (NHU) cells

Catalog No. 50-003-46831


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.